Pil Italica Life (PILITA)
Slow GrowerScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹8.48 |
| Market Cap | ₹199.28 Cr |
| P/E Ratio | 65.23 |
| ROCE | 8.9% |
| ROE | 5.84% |
| Dividend Yield | 0% |
| Profit Growth | -87.81% |
| Debt/Equity | 0.18 |
| Sales Growth | -30.32% |
| Promoter Holding | 50.09% |
| 52-Week Range | ₹6.2 — ₹15.9 |
| Sector | Consumer Durables |
| Book Value | ₹3.57 |
Strengths
- Low debt-to-equity ratio of 0.19 provides financial stability
- Promoter holding of 50.09% aligns management with shareholders
- Stock trades near 52-week low of ₹6.20, offering a potential value entry if fundamentals stabilize
- Latest quarter remains profitable with ₹1 Cr net profit on ₹30 Cr sales
- Book value of ₹3.26 gives some downside reference, though price is 2.47x book
Concerns
- Extremely high P/E of 44.44 for a business with declining profits
- Profit growth fell 53.85%, and sales growth is negative at -1.36%
- Low ROE of 5.84% and ROCE of 8.90% indicate poor capital efficiency
- Piotroski F-Score of 3/9 signals weak financial health; no dividend paid
AI Analysis
When I look at Pil Italica Life, I see a small plastic products company that fails my basic tests. At ₹8.06, the market caps it at ₹200 Cr, but the company earns only around ₹4.5 Cr trailing net profit – that's a P/E of 44.4. For that valuation, I expect a wonderful business, but what I get is a 5.84% ROE and a 8.90% ROCE. Even a fixed deposit could do better. The book value is ₹3.26, so I'm paying 2.47 times book for a business whose returns on that book are mediocre. Profit growth has collapsed by 53.85%, and sales are actually down 1.36%. The latest quarter shows just ₹1 Cr net profit on ₹30 Cr sales – a thin 3.3% margin. The Piotroski F-Score of 3 out of 9 is a red flag, pointing to deteriorating financial fundamentals. To be fair, the debt-to-equity is low at 0.19, and promoters hold 50.09%, showing some skin in the game. But no dividend, zero yield, and a price that has already fallen from a 52-week high of ₹15.90 to ₹8.06 still isn't cheap enough. I would rather wait for a margin of safety. At a P/E of 44, the market is pricing in a turnaround that I see no evidence for in the numbers. This is not a business I would buy; it is a business I would watch from a distance, hoping the price falls to a level where the asset value offers protection.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer